Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce Bischoff

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Tissue Engineering|September 14, 2006
Engineering of blood vessels from acellular collagen matrices coated with human endothelial cellsGilad E Amiel, Makoto Komura, Oz Shapira, et al.
Tissue Engineering. Part C, Methods|September 16, 2009
Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility studyJesper Hjortnaes, Danielle Gottlieb, Jose-Luiz Figueiredo, et al.
Anatomical Record (Hoboken, N.J. : 2007)|October 6, 2018
Filamin-A as a Balance between Erk/Smad Activities During Cardiac Valve DevelopmentKatelynn Toomer, Kimberly Sauls, Diana Fulmer, et al.
Vascular Pharmacology|March 28, 2024
Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosisBandana Singh, Kui Cui, Shahram Eisa-Beygi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2004
E-selectin is required for the antiangiogenic activity of endostatinYing Yu, Karen S Moulton, Mohamed K Khan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2011
Cyclic strain induces dual-mode endothelial-mesenchymal transformation of the cardiac valveKartik Balachandran, Patrick W Alford, Jill Wylie-Sears, et al.
Biochemical and Biophysical Research Communications|June 19, 2015
Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorinsHironao Nakayama, Lan Huang, Ryan P Kelly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2011
JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiationElisa Boscolo, Camille L Stewart, Shoshana Greenberger, et al.
British Journal of Pharmacology|May 20, 2015
The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesisNicole A Hofmann, Jiang Yang, Sunia A Trauger, et al.
JCI Insight|January 5, 2021
NOGOB receptor-mediated RAS signaling pathway is a target for suppressing proliferating hemangiomaWenquan Hu, Zhong Liu, Valerie Salato, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Tissue Engineering|September 14, 2006
Engineering of blood vessels from acellular collagen matrices coated with human endothelial cellsGilad E Amiel, Makoto Komura, Oz Shapira, et al.
Tissue Engineering. Part C, Methods|September 16, 2009
Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility studyJesper Hjortnaes, Danielle Gottlieb, Jose-Luiz Figueiredo, et al.
Anatomical Record (Hoboken, N.J. : 2007)|October 6, 2018
Filamin-A as a Balance between Erk/Smad Activities During Cardiac Valve DevelopmentKatelynn Toomer, Kimberly Sauls, Diana Fulmer, et al.
Vascular Pharmacology|March 28, 2024
Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosisBandana Singh, Kui Cui, Shahram Eisa-Beygi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2004
E-selectin is required for the antiangiogenic activity of endostatinYing Yu, Karen S Moulton, Mohamed K Khan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2011
Cyclic strain induces dual-mode endothelial-mesenchymal transformation of the cardiac valveKartik Balachandran, Patrick W Alford, Jill Wylie-Sears, et al.
Biochemical and Biophysical Research Communications|June 19, 2015
Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorinsHironao Nakayama, Lan Huang, Ryan P Kelly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2011
JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiationElisa Boscolo, Camille L Stewart, Shoshana Greenberger, et al.
British Journal of Pharmacology|May 20, 2015
The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesisNicole A Hofmann, Jiang Yang, Sunia A Trauger, et al.
JCI Insight|January 5, 2021
NOGOB receptor-mediated RAS signaling pathway is a target for suppressing proliferating hemangiomaWenquan Hu, Zhong Liu, Valerie Salato, et al.
Pageof 14